Composition for treating lung cancer

A composition and lung cancer technology, applied in the field of medicine, to achieve the effect of treating non-small cell lung cancer

Active Publication Date: 2018-05-04
THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHEN
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented product helps make medicine more accessible on rare types of tumors that are difficult or expensive to cure with traditional therapies like chemotherapy alone. It targets specific areas inside these tissues without affecting other parts of their body.

Problems solved by technology

This patented technical problem addressed in this patents relates to finding effective therapies against lung cancer without causing harmful side reactions such as brain damage due to their ability to kill cells through various mechanisms like apoptosis induction system activation, DNA repair mechanism enhancement, gene expression regulating agents, immune responses, antioxidants, etc., while avoiding being dependent on traditional medications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for treating lung cancer
  • Composition for treating lung cancer
  • Composition for treating lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] The extraction of embodiment 1 crocin

[0061] Soak the dried stigma of saffron in 400ml of 75 / 25 (V / V) methanol-water solution for 30 minutes, ultrasonically extract for 30 minutes, pour out the leaching solution, repeat the extraction three times, combine the saffron leaching solution obtained, vacuum filter, 50-60 ℃ condition The methanol was distilled off in a rotary evaporator.

[0062] Soak the D101 resin in 95% ethanol for 24h, wet the column with ethanol, and put the packing in the glass column, packing 50cm. Dissolve the obtained saffron crude extract in water, add it to the preparation column, and carry out gradient elution with ethanol-water solution: at 0-3h, the volume ratio of ethanol to water is 20:80; at 3-7h, ethanol The volume ratio of ethanol to water is 40:60, 7-9h, the volume ratio of ethanol to water is 60:40, 9-11h, the volume ratio of ethanol to water is 80:20, 11-14h, the volume ratio of ethanol to water The volume ratio is 95:5. Collect eac

Embodiment 2

[0063] Embodiment 2 Preparation of Erlotinib and Albumin Nanoparticle Composition Loaded with Crocin

[0064] (1) Preparation of saffron-loaded albumin nanoparticles;

[0065] 1) mixing the crocin drug in the organic phase, wherein the crocin drug is 10% of the organic phase;

[0066] 2) Dissolving albumin completely in deionized water, wherein the albumin is 1% of the aqueous medium;

[0067] 3) Shearing at a rotational speed of 5000 rpm for 5 minutes, slowly injecting the organic phase into the water phase while dispersing to obtain colostrum;

[0068] 4) Under the condition of 40000psi, the colostrum was subjected to high-pressure homogenization and repeated 5 times to obtain a homogeneously dispersed saffron-loaded albumin nanoparticle suspension;

[0069] 5) Rotating the obtained saffron-loaded albumin nanoparticle suspension at 40° C. for 60 minutes in vacuum to remove the organic phase;

[0070] 6) The saffron-loaded albumin nanoparticle suspension was passed through a

Embodiment 3

[0072] Example 3 Preparation of Erlotinib and Albumin Nanoparticle Composition Loaded with Crocin

[0073] (1) Preparation of saffron-loaded albumin nanoparticles;

[0074] 1) mixing the crocin medicine in the organic phase, wherein the crocin medicine is 80% of the organic phase;

[0075] 2) Dissolving albumin completely in deionized water, wherein the albumin is 10% of the aqueous medium;

[0076] 3) Shear at a rotational speed of 40,000 rpm for 5 minutes, and slowly inject the organic phase into the water phase while dispersing to obtain colostrum;

[0077] 4) Under the condition of 6000psi, the colostrum was subjected to high-pressure homogenization and repeated 30 times to obtain a homogeneously dispersed suspension of albumin nanoparticles loaded with saffron;

[0078] 5) Rotating the obtained saffron-loaded albumin nanoparticle suspension at 60° C. for 60 minutes in vacuum to remove the organic phase;

[0079] 6) The saffron-loaded albumin nanoparticle suspension was pa

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides a composition for treating lung cancer. The composition comprises erlotinib hydrochloride tablets and crocin albumin nanoparticles. By adopting the composition, the defects thatin the prior art combined medicines for effectively treating lung cancer are not available are overcome, and the composition which is remarkable in synergetic effect in treating lung cancer is provided.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products